In addition, a specific mutant EGFR, EGFRvIII, overexpressed on breast carcinomas, lung carcinomas, and other tumors, can be recognized by scFv mutant receptor 1 (MR1) (Wikstrand et al., 1995; Lorimer et al., 1996). This evidence concerns the gene EGFR and breast carcinoma.